Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data

被引:4
|
作者
Bahler, Caroline [1 ]
Rapold, Roland [1 ]
Signorell, Andri [1 ]
Reich, Oliver [1 ]
Panczak, Radoslaw [2 ]
Blozik, Eva [1 ,3 ]
机构
[1] Helsana Insurance Grp, Dept Hlth Sci, Zurich, Switzerland
[2] Univ Queensland, Sch Earth & Environm Sci, Queensland Ctr Populat Res, Brisbane, Qld, Australia
[3] Univ Med Ctr Freiburg, Dept Med, Freiburg, Germany
关键词
End-of-life care; Health care costs; Cause of death; Regional variation; Claims data; Intensity of treatment; INTENSITY; CANCER; MORTALITY; CULTURE;
D O I
10.1007/s00038-020-01428-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives We evaluated healthcare cost differences at the end of life (EOL) between language regions in Switzerland, accounting for a comprehensive set of variables, including treatment intensity. Methods We evaluated 9716 elderly who died in 2014 and were insured at Helsana Group, with data on final cause of death provided by the Swiss Federal Statistical Office. EOL healthcare costs and utilization, >= 1 ICU admission and 10 life-sustaining interventions (cardiac catheterization, cardiac assistance device implantation, pulmonary artery wedge monitoring, cardiopulmonary resuscitation, gastrostomy, blood transfusion, dialysis, mechanical ventilation, intravenous antibiotics, cancer chemotherapies) reimbursed by compulsory insurance were examined. Results Taking into consideration numerous variables, relative cost differences decreased from 1.27 (95% CI 1.19-1.34) to 1.06 (CI 1.02-1.11) between the French- and German-speaking regions, and from 1.12 (CI 1.03-1.22) to 1.08 (CI 1.02-1.14) between the Italian- and German-speaking regions, but standardized costs still differed. Contrary to individual factors, density of home-care nurses, treatment intensity, and length of inpatient stay explain a substantial part of these differences. Conclusions Both supply factors and health-service provision at the EOL vary between Swiss language regions and explain a substantial proportion of cost differences.
引用
收藏
页码:969 / 979
页数:11
相关论文
共 50 条
  • [1] Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data
    Yokoyama, Akihito
    Okazaki, Hiroshi
    Makita, Naoyuki
    Fukui, Ayako
    Piao, Yi
    Arita, Yoshifumi
    Itoh, Yohji
    Tashiro, Naoki
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (01) : 47 - 54
  • [2] End of life healthcare utilisation and costs of older patients receiving kidney replacement therapy-analysis of Dutch health insurance claims data
    Jongejan, Micha
    Van Oosten, Manon
    Leegte, Martijn
    van Buren, Marjolijn
    Abrahams, Alferso
    Bos, Willem Jan W.
    Voorend, Carlijn
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1369 - I1370
  • [3] The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome: An Observational Study Using Routine Health Insurance Data An observational study using routine health insurance data
    Haeuser, W.
    Marschall, U.
    Layer, P.
    Grobe, T.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2019, 116 (27-28): : 463 - +
  • [4] Retrieving and Analyzing Hospital Service Suspensions from Regional Healthcare Insurance Claims Data
    Sato, Jumpei
    Umemoto, Kazutoshi
    Goda, Kazuo
    Kitsuregawa, Masaru
    Mitsutake, Naohiro
    DIGITAL PERSONALIZED HEALTH AND MEDICINE, 2020, 270 : 407 - 411
  • [5] BEST SUPPORTIVE CARE COSTS AND HEALTHCARE USE DURING END-OF-LIFE CARE IN TERMINAL CANCER PATIENTS IN SOUTH KOREA: A RETROSPECTIVE OBSERVATIONAL STUDY FROM NATIONWIDE CLAIMS COHORT DATA
    Kang, D.
    Shim, Y. B.
    Mi-Hai, P.
    VALUE IN HEALTH, 2020, 23 : S432 - S432
  • [6] END-OF-LIFE COSTS IN MULTIPLE SCLEROSIS: AN ANALYSIS OF MEDICARE CLAIMS DATA
    Watzker, A.
    Sussman, M.
    Friedman, M.
    Menzin, J.
    VALUE IN HEALTH, 2022, 25 (07) : S396 - S396
  • [7] END OF LIFE HEALTHCARE COSTS IN HEART FAILURE: DIFFERENCES BASED ON RACE/ETHNICITY
    Swindle, Jason P.
    Obi, Engels
    Turner, Stuart
    Russo, Patricia A.
    Chang, Chun-Lan
    Blauer-Peterson, Cori
    Wacha, Lynn
    Altan, Aylin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1408 - 1408
  • [8] HEALTHCARE COSTS OF PATIENTS ON DIFFERENT RENAL REPLACEMENT MODALITIES - ANALYSIS OF DUTCH HEALTH INSURANCE CLAIMS DATA
    van Oosten, Manon
    Mohnen, Sigrid
    Los, Jeanine
    Leegte, Martijn
    Jager, Kitty
    Hemmelder, Marc
    Logtenberg, Susan
    Stel, Vianda
    Hakkaart-van Roijen, Leona
    de Wit, G. Ardine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [9] Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data
    Mohnen, Sigrid M.
    van Oosten, Manon J. M.
    Los, Jeanine
    Leegte, Martijn J. H.
    Jager, Kitty J.
    Hemmelder, Marc H.
    Logtenberg, Susan J. J.
    Stel, Vianda S.
    Hakkaart-van Roijen, Leona
    de Wit, G. Ardine
    PLOS ONE, 2019, 14 (08):
  • [10] Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study
    Lal, Lincy S.
    Aly, Abdalla
    Le, Lisa B.
    Peckous, Susan
    Seal, Brian
    Teitelbaum, April
    CANCER REPORTS, 2022, 5 (05)